Search Results - "Tasnády, Szabolcs"

Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL by Rendeiro, André F., Krausgruber, Thomas, Fortelny, Nikolaus, Zhao, Fangwen, Penz, Thomas, Farlik, Matthias, Schuster, Linda C., Nemc, Amelie, Tasnády, Szabolcs, Réti, Marienn, Mátrai, Zoltán, Alpár, Donát, Bödör, Csaba, Schmidl, Christian, Bock, Christoph

“…The Bruton tyrosine kinase (BTK) inhibitor ibrutinib provides effective treatment for patients with chronic lymphocytic leukemia (CLL), despite extensive…”
Get full text

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans by Vályi-Nagy, István, Matula, Zsolt, Gönczi, Márton, Tasnády, Szabolcs, Bekő, Gabriella, Réti, Marienn, Ajzner, Éva, Uher, Ferenc

“…In the present study, humoral and T cell-mediated immune responses elicited by BBIBP-CorV (inactivated virus) and BNT162b2 (mRNA-based) vaccines against…”
Get full text

Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency by Goda, Vera, Kriván, Gergely, Kulcsár, Andrea, Gönczi, Márton, Tasnády, Szabolcs, Matula, Zsolt, Nagy, Ginette, Bekő, Gabriella, Horváth, Máté, Uher, Ferenc, Szekanecz, Zoltán, Vályi-Nagy, István

“…Common variable immunodeficiency (CVID) patients have markedly decreased immune response to vaccinations. In this study we evaluated humoral and T…”
Get full text

Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib by Gángó, Ambrus, Alpár, Donát, Galik, Bence, Marosvári, Dóra, Kiss, Richárd, Fésüs, Viktória, Aczél, Dóra, Eyüpoglu, Ediz, Nagy, Noémi, Nagy, Ákos, Krizsán, Szilvia, Reiniger, Lilla, Farkas, Péter, Kozma, András, Ádám, Emma, Tasnády, Szabolcs, Réti, Marienn, Matolcsy, András, Gyenesei, Attila, Mátrai, Zoltán, Bödör, Csaba

“…The Bruton's tyrosine kinase (BTK) inhibitor ibrutinib is inducing durable responses in chronic lymphocytic leukemia (CLL) patients with refractory/relapsed…”
Get full text

Early Experience With CliniMACS Prodigy CCS (IFN-gamma) System in Selection of Virus-specific T Cells From Third-party Donors for Pediatric Patients With Severe Viral Infections After Hematopoietic Stem Cell Transplantation by Kállay, Krisztián, Kassa, Csaba, Réti, Marienn, Karászi, Éva, Sinkó, János, Goda, Vera, Stréhn, Anita, Csordás, Katalin, Horváth, Orsolya, Szederjesi, Attila, Tasnády, Szabolcs, Hardi, Apor, Kriván, Gergely

“…Viral reactivation is a frequent complication of allogeneic hematopoietic stem cell transplantation especially in children. For refractory cases, rapid…”
Get full text

IGH::NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma by Bors, András, Kozma, András, Tomán, Ágnes, Őrfi, Zoltán, Kondor, Nóra, Tasnády, Szabolcs, Vályi-Nagy, István, Reményi, Péter, Mikala, Gábor, Andrikovics, Hajnalka

“…Multiple myeloma (MM) is the second most common hematological malignancy. Approximately 15% of MM patients are affected by the t(4;14) translocation resulting…”
Get full text

Effective virus-specific T-cell therapy for high-risk SARS-CoV-2 infections in hematopoietic stem cell transplant recipients: initial case studies and literature review by Gopcsa, László, Réti, Marienn, Andrikovics, Hajnalka, Bobek, Ilona, Bekő, Gabriella, Bogyó, Judit, Ceglédi, Andrea, Dobos, Katalin, Giba-Kiss, Laura, Jankovics, István, Kis, Orsolya, Lakatos, Botond, Mathiász, Dóra, Meggyesi, Nóra, Miskolczi, Gottfried, Németh, Noémi, Paksi, Melinda, Riczu, Alexandra, Sinkó, János, Szabó, Bálint, Szilvási, Anikó, Szlávik, János, Tasnády, Szabolcs, Reményi, Péter, Vályi-Nagy, István

“…The COVID-19 pandemic has exacerbated mortality rates among immunocompromised patients, accentuating the need for novel, targeted therapies. Transplant…”
Get full text

Identification of the best‐suited donor for generating virus‐specific T cells by Tasnády, Szabolcs, Karászi, Éva, Szederjesi, Attila, Bihari, György, Juhász, Zsófia, Hardi, Apor, Kriván, Gergely, Kállay, Krisztián, Reményi, Péter, Sinkó, János, Mikala, Gábor, Réti, Marienn, Masszi, Tamás

“…Background and objectives Administration of virus‐specific T cells (VSTs) is a viable antiviral treatment strategy after allogeneic HSCT, even if conventional…”
Get full text

Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 Non-Responsive to Standard Treatment: A Pilot Investigational Study by Szabó, Bálint Gergely, Reményi, Péter, Tasnády, Szabolcs, Korózs, Dorina, Gopcsa, László, Réti, Marienn, Várkonyi, Andrea, Sinkó, János, Lakatos, Botond, Szlávik, János, Bekő, Gabriella, Bobek, Ilona, Vályi-Nagy, István

“…The optimal approach for adult patients hospitalized with severe and critical coronavirus disease 2019 (COVID-19), non-responsive to antiviral and…”
Get full text

A Novel, Closed-Line Mini Extracorporeal Photopheresis (ECP) Technique Using the Therakos TM CellEx TM Photopheresis System, Developed for Patients with Contraindications Against Conventional ECP Therapy by Várkonyi, Andrea, Kállay, Krisztián, Dobos, Katalin, Tasnády, Szabolcs, Reményi, Péter, Reti, Marienn

“…Introduction: Conventional ECP has proven efficacy for treating several diseases, most significantly steroid-refractory chronic GVHD. Unfortunately, body…”
Get full text

Newly Diagnosed Chronic Lymphocytic Leukemia During Symptomatic COVID-19: Two Cases by Papp, Enikő, Tasnády, Szabolcs, Tisza, Katalin, Király, Ágnes, Bekő, Gabriella

Get full text

IIGH::NSD2/I Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma by Bors, András, Kozma, András, Tomán, Ágnes, Őrfi, Zoltán, Kondor, Nóra, Tasnády, Szabolcs, Vályi-Nagy, István, Reményi, Péter, Mikala, Gábor, Andrikovics, Hajnalka

“…Multiple myeloma is the second most common malignant hematologic cancer. In approximately 15% of cases, a chromosomal abnormality, t(4;14), leads to…”
Get full text

Dissection of Clonal Evolution By Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib by Alpár, Donát, Marosvári, Dóra, Kiss, Richárd, Fésüs, Viktória, Gángó, Ambrus, Nagy, Noémi, Farkas, Péter, Tasnády, Szabolcs, Réty, Marienn, Matolcsy, Andras, Mátrai, Zoltán, Bödör, Csaba

“…Introduction: The irreversible Bruton tyrosine kinase (BTK) inhibitor ibrutinib is changing the paradigm of the treatment of chronic lymphocytic leukemia (CLL)…”
Get full text

Allogeneic hematopoietic stem cell transplantation in Hungary by Bátai, Árpád, Reményi, Péter, Réti, Marienn, Barta, Anikó, Gopcsa, László, Lengyel, Lilla, Torbágyi, Éva, Csukly, Zoltán, Karászi, Éva, Tordai, Attila, Andrikovics, Hajnalka, Balassa, Katalin, Tasnády, Szabolcs, Masszi, Tamás

“…The publication summarizes the 2548 stem cell transplantations performed in the period of 1993-2015 in Szent Laszló Hospital, Budapest and provides a detailed…”
Get more information

Dissection of Subclonal Evolution by Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib by Gángó, Ambrus, Alpár, Donát, Galik, Bence, Marosvári, Dóra, Kiss, Richárd, Fésüs, Viktória, Aczél, Dóra, Nagy, Noémi, Nagy, Ákos, Krizsán, Szilvia, Reiniger, Lilla, Farkas, Péter, Kozma, András, Ádám, Emma, Tasnády, Szabolcs, Réti, Marienn, Matolcsy, András, Gyenesei, Attila, Mátrai, Zoltán, Bödör, Csaba

Get full text

Non-malignant, non-infectious lymphoproliferation: challenges in the diagnosis and treatment of autoimmune lymphoproliferative syndrome by Molnár, Emese, Kovács, Gábor, Varga, Lívia, Tasnády, Szabolcs, Bors, András, Tankó, Lenke, Csabán, Dóra, Kapócs, Katalin, Nemes-Nagy, Zsuzsanna, Andrikovics, Hajnalka

“…Összefoglaló. Az autoimmun lymphoproliferativ szindróma egy ritka, immundeficientiával járó genetikai betegség. Hátterében az extrinszik apoptotikus útvonal…”
Get more information